NCT04853017: A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors
- State
- Completed
- Phase
- Phase 1
- People
- 25 taking part
- Started
- 4 Oct 2021
- Primary completion
- 26 Jan 2023
- Arms
- ELI-002 2P Cohort 1, ELI-002 2P Cohort 2, ELI-002 2P Cohort 3, ELI-002 2P Cohort 4, ELI-002 2P Cohort 5
- Results
- Posted on the registry
- 21 Apr 2021: Trial registered
- 4 Oct 2021: Trial started
- 24 Sep 2024: Trial completed
- 17 Jan 2025: Trial results posted